These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent. Blechman M; Sokol C; Moser M Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816 [No Abstract] [Full Text] [Related]
5. Preliminary experience with a new postganglion-blocking agent for the management of hypertension. Belle MS; Gilmore HR; Keyes MH; Sanford H J Fla Med Assoc; 1968 Dec; 55(12):1081-4. PubMed ID: 4881916 [No Abstract] [Full Text] [Related]
7. [Therapeutic effects of debrisoquine sulfate in hypertension]. Liu HW; Chen CY Taiwan Yi Xue Hui Za Zhi; 1972 Mar; 71(3):189-95. PubMed ID: 4506851 [No Abstract] [Full Text] [Related]
8. Clinical study of the antihypertensive effects of debrisoquin sulfate in combination with hydrochlorothiazide. Schultz FB J Med Assoc State Ala; 1966 Aug; 36(2):147-53. PubMed ID: 5329755 [No Abstract] [Full Text] [Related]
9. [Clinical trials of a new hypotensive agent, R.O. 5,3307]. Jouve A; Medvedowsky JL; Poggi L Mars Med; 1966; 103(10):745-50. PubMed ID: 5959766 [No Abstract] [Full Text] [Related]
10. [New antihypertensive drugs. II. Debrisoquin or Declinax]. Amery A; Deruyttere M; Fagard R; Koninckx P Acta Clin Belg; 1970; 25(5):317-34. PubMed ID: 5513889 [No Abstract] [Full Text] [Related]
11. Debrisoquine. A five-year study of a new hypotensive agent. Bauer GE Med J Aust; 1970 Nov; 2(20):911-5. PubMed ID: 5486292 [No Abstract] [Full Text] [Related]
12. Interaction between debrisoquine and phenylephrine. Aminu J; D'Mello A; Vere DW Lancet; 1970 Oct; 2(7679):935-6. PubMed ID: 4097321 [No Abstract] [Full Text] [Related]
13. Clinical observations on the effects of debrisoquine sulphate in patients with high blood-pressure. Athanassiadis D; Cranston WI; Juel-Jensen BE; Oliver DO Br Med J; 1966 Sep; 2(5516):732-5. PubMed ID: 5917391 [No Abstract] [Full Text] [Related]
15. [Clinical experience with a new postganglionie blockader (Debriosquin, R0-5-3307)]. Ocon Pujadas J Rev Clin Esp; 1972 Jun; 125(6):521-32. PubMed ID: 5074965 [No Abstract] [Full Text] [Related]
16. [Treatment of arterial hypertension. Preliminary clinical observations using RO 5-3307 (Declinax)]. Faria E; Leite PP; de Loyola Buquera LA; Selmi AE; do Amarilho IP; de Freitas AP Hospital (Rio J); 1967 Feb; 71(2):476-9. PubMed ID: 5302399 [No Abstract] [Full Text] [Related]
17. Short report: ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents. Canter DA; Texter MJ; McLain RW J Hypertens; 1994 Apr; 12(4):491-4. PubMed ID: 8064175 [No Abstract] [Full Text] [Related]
18. Guanfacine: a new centrally-acting antihypertensive agent. Beevers DG; Bloxham CA; Walker JM Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931 [TBL] [Abstract][Full Text] [Related]
19. Clinical observations on the use of debrisoquine sulphate (Declinas) in the treatment of hypertension. Heffernan AG; Carty AT Ir J Med Sci; 1970 Jan; 3(1):37-43. PubMed ID: 5444549 [No Abstract] [Full Text] [Related]